Over the last 7 days, the Pharma industry has remained flat, although notably Merck gained 4.4%. The past year has been better, since the industry has gained 11% in that time. Looking forward, earnings are forecast to grow by 23% annually.
Has the U.S. Pharma Industry valuation changed over the past few years?
Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
---|---|---|---|---|---|---|
Fri, 26 Apr 2024 | US$1.8t | US$359.5b | US$17.5b | 21.9x | 101.6x | 5x |
Sun, 24 Mar 2024 | US$1.9t | US$355.3b | US$22.6b | 19.8x | 82.6x | 5.3x |
Tue, 20 Feb 2024 | US$1.9t | US$355.0b | US$23.9b | 28.3x | 79.4x | 5.4x |
Thu, 18 Jan 2024 | US$1.8t | US$375.2b | US$33.9b | 27.6x | 51.7x | 4.7x |
Sat, 16 Dec 2023 | US$1.6t | US$375.1b | US$33.9b | 26.7x | 48.6x | 4.4x |
Mon, 13 Nov 2023 | US$1.6t | US$375.5b | US$34.1b | 26.5x | 47.6x | 4.3x |
Wed, 11 Oct 2023 | US$1.7t | US$381.8b | US$43.8b | 18.1x | 38.6x | 4.4x |
Fri, 08 Sep 2023 | US$1.8t | US$381.8b | US$43.9b | 19.3x | 41.3x | 4.7x |
Sun, 06 Aug 2023 | US$1.7t | US$379.8b | US$43.1b | 21.5x | 39.1x | 4.4x |
Tue, 04 Jul 2023 | US$1.7t | US$392.8b | US$60.2b | 18.6x | 29x | 4.4x |
Thu, 01 Jun 2023 | US$1.7t | US$393.0b | US$60.6b | 17.8x | 27.7x | 4.3x |
Sat, 29 Apr 2023 | US$1.7t | US$400.2b | US$62.2b | 17.4x | 27x | 4.2x |
Mon, 27 Mar 2023 | US$1.6t | US$401.2b | US$69.5b | 14.7x | 22.3x | 3.9x |
Wed, 22 Feb 2023 | US$1.6t | US$401.7b | US$68.4b | 17.9x | 23.6x | 4x |
Fri, 20 Jan 2023 | US$1.7t | US$403.7b | US$70.6b | 17.7x | 23.9x | 4.2x |
Sun, 18 Dec 2022 | US$1.7t | US$403.7b | US$70.7b | 16.7x | 24.6x | 4.3x |
Tue, 15 Nov 2022 | US$1.7t | US$403.6b | US$71.1b | 12.9x | 24x | 4.2x |
Thu, 13 Oct 2022 | US$1.6t | US$403.0b | US$71.3b | 12.2x | 21.8x | 3.9x |
Sat, 10 Sep 2022 | US$1.6t | US$403.0b | US$71.3b | 14x | 22.5x | 4x |
Mon, 08 Aug 2022 | US$1.6t | US$403.3b | US$69.5b | 19.3x | 23.5x | 4.1x |
Wed, 06 Jul 2022 | US$1.7t | US$392.4b | US$65.1b | 22.1x | 26x | 4.3x |
Fri, 03 Jun 2022 | US$1.7t | US$392.5b | US$64.8b | 21.5x | 25.7x | 4.2x |
Sun, 01 May 2022 | US$1.6t | US$380.0b | US$61.3b | 20.5x | 26.7x | 4.3x |
Tue, 29 Mar 2022 | US$1.7t | US$373.8b | US$60.4b | 22.2x | 27.4x | 4.4x |
Thu, 24 Feb 2022 | US$1.5t | US$373.4b | US$59.2b | 20.8x | 25.4x | 4x |
Sat, 22 Jan 2022 | US$1.6t | US$361.3b | US$37.7b | 22.8x | 41.4x | 4.3x |
Mon, 20 Dec 2021 | US$1.6t | US$361.1b | US$38.1b | 22.6x | 42.9x | 4.5x |
Wed, 17 Nov 2021 | US$1.6t | US$360.6b | US$38.5b | 24.1x | 41.4x | 4.4x |
Fri, 15 Oct 2021 | US$1.5t | US$337.7b | US$24.8b | 21.6x | 60x | 4.4x |
Sun, 12 Sep 2021 | US$1.5t | US$338.7b | US$25.4b | 18.4x | 60.1x | 4.5x |
Tue, 10 Aug 2021 | US$1.6t | US$338.5b | US$25.8b | 21.9x | 61.7x | 4.7x |
Mon, 03 May 2021 | US$1.4t | US$315.6b | US$19.6b | 18.8x | 71.9x | 4.5x |
71.9x
How does U.S. Pharma compare with similar industries?
US Market | 0.97% | |
Healthcare | 0.76% | |
Pharma | -0.56% | |
Pharma | -0.56% |
Which companies have driven the market over the last 7 days?
Company | Last Price | 7D | 1Y | Valuation | |
---|---|---|---|---|---|
MRK Merck | US$130.72 | 4.4% +US$13.9b | 13.5% | PE143.6x | |
JNJ Johnson & Johnson | US$146.82 | 0.7% +US$2.6b | -9.9% | PE18.5x | |
TEVA Teva Pharmaceutical Industries | US$13.25 | 3.7% +US$532.3m | 55.5% | PS0.9x | |
VTRS Viatris | US$11.47 | 3.1% +US$415.6m | 23.9% | PE249x | |
AXSM Axsome Therapeutics | US$71.52 | 8.8% +US$274.8m | 0.5% | PS12.5x |